VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 23, 2008) - Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular disease today announced a poster was presented by Dr. Mark Basik, McGill University, at the American Association for Cancer Research (AACR) Annual Meeting held in San Diego, California. The poster showed positive CTCE-9908 data results in the treatment of breast cancer in a preclinical model.
